Beasley Allen in Vioxx News

Articles 1 to 10 of 96 .

Merck to pay nearly $1 billion for illegal marketing of Vioxx

American pharmaceutical company Merck, Sharp & Dohme has agreed to pay $950 million to resolve criminal charges and civil claims related to its promotion and marketing of the painkiller Vioxx® (rofecoxib), the Justice Department announced today.

Merck paying more than 3,100 vioxx death claims

Merck & Co. is paying claims by the families of more than 3,100 users of its Vioxx painkiller who died of heart attacks or strokes blamed on the drug, according to a law firm administering a $4.85 billion settlement fund.

Settlement limits insurers' claims in Vioxx deal

TRENTON, N.J. (AP) -- Former Vioxx users getting part of a $4.85 billion settlement ending most personal injury suits over the withdrawn painkiller will get a bigger piece of the pie, thanks to an unusual settlement Thursday with their health insurers.

Merck will fund Vioxx settlement in August

Pharmaceutical company Merck says it will start cutting checks next month for former users of its withdrawn painkiller Vioxx. Merck announced plans today to fund the $4.8 billion settlement involving about 50,000 lawsuits.

Merck to fund Vioxx settlement in August

Merck & Co. will start cutting checks for former users of its withdrawn painkiller Vioxx next month after announcing Thursday that it will fund a $4.85 billion settlement expected to resolve roughly 50,000 lawsuits alleging harm from Vioxx.

Merck to start Vioxx settlement payouts in August

Merck & Co. will start cutting checks for former users of its withdrawn painkiller Vioxx next month after announcing Thursday that it will fund a $4.85 billion settlement expected to resolve roughly 50,000 lawsuits.

Vioxx criticism may tarnish Merck but settlement safe

Renewed criticism of Merck & Co's handling of its withdrawn pain drug Vioxx may further tarnish the drugmaker's image but is not about to scuttle its multibillion-dollar deal to settle thousands of personal injury lawsuits brought by former Vioxx users.

Merck Says 44K Sign for Vioxx Settlement

More than 44,000 people have signed up for shares of a $4.85 billion settlement over the withdrawn painkiller Vioxx, a sign that the deal is on track to go forward, Merck & Co. announced Monday. Of roughly 47,000 people who registered for the settlement earlier this year, more than 44,000 have submitted all or some of the paperwork necessary for enrollment in the deal, Merck said in a news release.

Lawyers Resolve Ethical Concerns In Vioxx Settlement

A federal judge overseeing a $4.85 billion settlement with Merck & Co. involving its withdrawn Vioxx painkiller expressed confidence Friday that lawyers have resolved ethical concerns about the agreement.

Vioxx Settlement Gaining Ground with 95 Percent of Plaintiffs Signing On

The pending Merck Vioxx settlement appears to be on track, as more than 95 percent of possible Vioxx claimants have signed on to Merck's $4.85 million settlement offer.